LINC00324

Across TCGA pan-cancer cohorts, LINC00324 RNA is linked to patient survival in 26 of 34 cancer types, making it the most broadly survival-associated LINC00324 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher LINC00324 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated LINC00324 expression acts as an unfavorable survival marker, although some lineages such as LUAD and SKCM show a favorable association.

LUAD, SKCM, and KIRC are the cancer types where LINC00324 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Median	All	0.737	0.589	<.001	103	view →
SKCM	OS	Median	All	0.430	0.255	<.001	81	view →
KIRC	DFS	Median	II,III,IV	0.814	0.494	<.001	71	view →
UCEC	OS	Quartile	All	0.783	0.512	.002	60	view →
HNSC	DFS	Quartile	IV	0.786	0.566	.001	59	view →
LGG	OS	Median	All	0.374	0.526	<.001	53	view →
LIHC	OS	Quartile	All	0.676	0.428	.001	43	view →
UVM	DFS	Median	III,IV	0.430	0.924	.002	42	view →
BLCA	OS	Tertile	All	0.780	0.647	.005	38	view →
MESO	OS	Quartile	All	0.618	0.268	<.001	26	view →
SARC	OS	Tertile	All	0.849	0.631	<.001	25	view →
UCS	DFS	Tertile	IV	0.956	0.380	.024	24	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 26 lineages.

LINC00324–LUAD (DFS)

Open the LUAD breakdown →